NCT04979741 (RAI) is a clinical trial of No interventions in Follow up, sponsored by University of Genova.

Who is sponsoring NCT04979741?

NCT04979741 is sponsored by University of Genova.

What drugs are being tested in NCT04979741?

Interventions in NCT04979741: No interventions.

What condition does NCT04979741 study?

NCT04979741 studies Follow up, Outcome, Intensive Care Unit Syndrome.

Is NCT04979741 still recruiting?

NCT04979741 is currently status unknown. Last updated 28 July 2021.

Last reviewed 2021-07-28 · How we verify

NCT04979741: RAI

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Recovery After Intensive Care Study

Status unknown Last updated 28 July 2021

What this trial tests

trial testing No interventions in Follow up in 196 participants. Status unknown.

Timeline

1 January 2021

Primary endpoint
1 January 2021

1 January 2023

Quick facts

Lead sponsor	University of Genova
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	196
Start date	1 January 2021
Primary completion	1 January 2021
Estimated completion	1 January 2023
Sites	1 location across Italy

Drugs / interventions tested

No interventions — full drug profile →

Conditions studied

Follow up — all drugs for Follow up →
Outcome — all drugs for Outcome →
Intensive Care Unit Syndrome — all drugs for Intensive Care Unit Syndrome →

Sponsor

University of Genova

Who can join

18 and older, any sex, with Follow up or Outcome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Post-ICU long term sequelae- defined as "post intensive care syndrome" (PICS) manifest with a wide spectrum of psychological and cognitive impairments, affecting over two-thirds of ICU survivors and leading to increased rehospitalization, health care costs, impaired quality of life (QoL), inability to return to work and burden for families. The prevalence of post-traumatic stress symptoms (PTSD), anxiety symptoms, and depression after ICU stay is high and has been demonstrated in up to 50% of post-ICU population. Therefore, over the last years, an important effort has been made for the development of ICU aftercare and follow-up clinics with the aim to detect and to minimize post-ICU sequelae and improve outcomes. However, the utility of these follow-up programs and their effect on outcome has not been completely demonstrated.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of No interventions

Trials testing the same drug.

NCT07497815 — Artificial Intelligence-assisted Diagnosis in Ophthalmology · not yet recruiting
NCT07509632 — Predicting Pathological Complete Response in Rectal Cancer Using Machine Learning · active not recruiting
NCT07307040 — Precision Diabetes Management: Integrated East-West Approach · not yet recruiting
NCT07276945 — Individualized Early Diagnosis and Treatment System of Gestational Diabetes Mellitus (GDM) Based on New Continuous Gluco · not yet recruiting
NCT06999681 — Postoperative Arrhythmia and Preoperative Cardiac Function · not yet recruiting

Other University of Genova trials

Trials by the same sponsor.

NCT07351435 — The Caribbean Registry of Extracorporeal Membrane Oxygenation (ECMO) From the University Hospital in Martinique · not yet recruiting
NCT06689020 — Positive Expiratory Pressure (PEP) and Continuous High-frequency Oscillation (CHFO) on Lung RECRUITment Using Electrical · not yet recruiting
NCT06367816 — Brain Recovery With Automated VEntilation · completed
NCT05467579 — Mandibular Advancement Clear Aligner Treatment in Juvenile Idiopathic Arthritis Subjects · NA · unknown
NCT05135962 — Maxillary Expansion: Leaf Expander Versus Hyrax Expander · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04979741 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Genova
Last refreshed: 28 July 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04979741.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing